Health & Biotechnology

Projects Establishment(s) IP Actions

3D-CELLS

(Français) DISPOSITIF INNOVANT DE CULTURE CELLULAIRE EN 3 DIMENSIONS

(Français) CNRS, UM, ENSCM, INSERM (Français) Brevet

SPIMA PROJECT

(Français) Développement de peptides agrafés pour le traitement des maladies inflammatoires

(Français) UM, CHU Montpellier, INSERM, CNRS Patent

NODIA

nNOS/PIN interaction inhibitors for diabetes type 2 treatment

BC2M: Cardiometabolic biocommunication N/A

DIVINS

Innovative implantable medical device for endovascular treatment of cerebral aneurysms

Montpellier CHU – UM - CNRS Patent

EPIDROP

Microfluid system to sort, characterize, and select ctc isolated in droplets

CHU, Laboratoire Chimie Biologie Innovation, CNRS, ESPCI (Paris Higher School of Industrial Physics and Chemistry), UPMC (University Pierre and Marie Curie), and University of Montpellier Patent

INHIBITORS OF TCPases

Development of a new class of therapeutic molecules to modulate TCPases

CNRS, University of Montpellier Patent

INTEGRACELLS

Non-invasive quality control test for pluripotent stem cells

INSERM, Montpellier CHU, University of Montpellier Patent

Vaccine against the disease of Newcastle

New vaccine against newcastle disease for clinical protection and to prevent excretion

CIRAD INRA Patent

P42

Preclinical development of P42 peptide, orphan drug for Huntington’s disease

University of Montpellier,Inserm, CNRS, EPHE Patent

TZ-PEP

Innovative strategy to improve stability and permeability of therapeutic peptides

UPVD, UM, CNRS, EPHE, INSERM Patent

RPA PROJECT

Retinitis Punctata Albescens (RPA) is a pigmentary retinopathy that leads to blindness, and for which there is currently no cure. The project team wants to demonstrate the efficacy of gene therapy for treating this disease.

INSERM Patent

ANTI-HIV CARBONUCLEOSIDE PHOSPHONATES

Development of a phosphonate carbonucleoside presenting very significant activity on the AIDS virus in cell cultures.

CNRS, University of Montpellier, ENSCM Patent

TELE-MOUV

Development of a medically validated remote rehabilitation solution to improve the prevention and handling of chronic diseases. Non-drug therapies, structured physical activity, and nutrition are personalized and adapted in real-time by leveraging connected objects and specially-developed algorithms.

INSERM, CNRS, University of Montpellier N/A

HAMLET-TEST

Behavior testing device designed to evaluate the topographical memory of mice in complex environments. The device automatically collects numerous types of information (movement, ingestion of food, water intake, physical activity, etc.) and is based on habituating the animal to a complex and enhanced environment.

INSERM, University of Montpellier, EPHE Patent

PHLEBOSTHENE PROJECT

Complete system for body volumetrics and quantitative study of biomechanical parameters in human member veins, enabling personalized configuration of compression treatments for venous insufficiency and lymphedema.

University of Montpellier, CNRS, CHRU Montpellier, CHU Nîmes Patent

PROV & CARE

International scientific intelligence on non-drug interventions, analysis, meta-analysis and territorial extrapolation, non-drug clinical research consulting.

University of Montpellier (UM), University Paul Valéry (UPV) N/A

ERGOSTEROL PROJECT

Development of an activation process of the sterol biosynthesis pathway, resulting in the overproduction of sterols and sterol derivatives.

Montpellier Sup Agro, Inra, University of Montpellier Patent

SEQONE PROJECT

CORTECT offers a high-throughput sequencing data analysis (NGS) service in SaaS mode. This all-in-one solution is customizable, accessible, and easy to interpret, while offering unparalleled performance.

University of Montpellier, Inserm Software licensing

eDENT PROJECT

e-DENT is a software solution that enables dental surgeons to read and analyze images and videos recorded remotely with an intra-oral digital camera using fluorescence

University of Montpellier, CHRU Software licensing

RARE

Identification and tracking of cell populations of interest in predictive medicine using static learning methods applied to flow cytometry data

UM, CNRS, Bordeaux CHU, Montpellier CHU, Inserm Patent